The precise locations of attachment points of muscle to bone-the origin and insertion sites-are crucial anatomical and functional characteristics that influence locomotor performance. Mechanisms that control the development of these interactions between muscle, tendon, and bone are currently not well understood. In a subset of BXD recombinant inbred (RI) strains derived from the C57BL/6J and DBA/2J strains, we observed a soleus femoral attachment anomaly (SFAA) that was rare in both parental strains (Lionikas, Glover et al. 2006) . The aim of the present study was to assess suitability of SFAA as a model to study the genetic mechanisms underlying variation in musculoskeletal anatomy. We scored the incidence of SFAA in 55 BXD strains (n 5 9 to 136, median 5 26, phenotyped animals per strain, for a total number of 2367). Seven strains (BXD1, 12, 38, 43, 48, 54, and 56) exhibited a high incidence of unilateral SFAA (47-89%), whereas 23 strains scored 0%. Exploration of the mechanisms underlying SFAA in 2 high incidence strains, BXD1 and BXD38, indicated that SFAArelevant genes are to be found in both C57BL/6J and DBA/2J regions of the BXD1 genome. However, not all alleles relevant for the expression of the phenotype were shared between the 2 high-incidence BXD strains. In conclusion, the anatomical origin of the soleus muscle in mouse is controlled by a polygenic system. A panel of BXD RI strains is a useful tool in exploring the genetic mechanisms underlying SFAA and improving our understanding of musculoskeletal development.
Individual muscles are characterized by specific regions of skeletal origin and insertion and can operate across single or multiple joints. Position and size of the area of muscle attachment to a bone is a relevant characteristic at a finer scale, affecting biomechanical transmission of generated force to skeleton. For instance, the soleus muscle of humans originates at the posterior surface of the head and upper shaft of the fibula, and soleal line of the tibia. It inserts at the dorsum of the calcaneus via the Achilles tendon. A certain degree of variation in anatomical characteristics has been noted; examination of human cadavers has shown a high level of individual variability, for instance, the length of the soleus attachment area on the tibia ranges from 5 to 14 cm for bones of a similar size (Ekenman et al. 1995) . In addition to those quantitative differences, qualitative differences such as the absence of a tibial attachment (Ekenman et al. 1995) and a shift of the fibular attachment of the soleus to the fibular collateral ligament of the femur (Barberini et al. 2003) have also been reported. It is likely that these anatomical variants alter the transmission of force resulting in postural and locomotor variations and may underlie the susceptibility of some individuals to shin splint and stress fractures (Ekenman et al. 1995) . Some of the variation in anatomical characteristics might be an outcome of prenatal perturbations of development; however, familial resemblance in gait and posture also indicates the role of genetic factors.
There is a significant degree of resemblance in musculoskeletal anatomy across species demonstrating that the underlying mechanisms are evolutionarily conserved (Nguyen and Frasch 2006; Wellik 2007) . We have recently reported a soleus femoral attachment anomaly (SFAA) in hindlimb of mice of the C57BL/6J (B6) and DBA/2J (D2) lineage (Lionikas, Glover et al. 2006) . SFAA is manifested as a shift of the origin of soleus muscle across the knee joint from the proximal fibula to the distal femur ( Figure 1 ). Importantly, a high incidence of this anomaly is found in a subset of BXD recombinant inbred (RI) strains that are the offspring of a cross between B6 and D2. This genetically controlled variation in musculoskeletal organization presents a model that can be exploited to shed light on the factors guiding tendons to a specific anatomical site of the skeleton, an important developmental process which is incompletely understood (Kardon 1998; Tozer and Duprez 2005) .
Materials and Methods

Animals and Phenotype
Male and female mice from 55 BXD RI strains and the C57BL/6J (B6) and DBA/2J (D2) strains and various crosses (see below for details) were phenotyped. Under a dissection scope the soleus muscle was exposed by removing the gastrocnemius. The Achilles tendon was cut just below the soleus and carefully retracted upward from the fibula until the region of the origin of the proximal tendon (fibula or femur) was clearly visible. Strain incidence of the SFAA was expressed as a percentage of mice expressing SFAA (unilaterally or bilaterally) of the total number of examined animals. Standard error of strain mean proportion was derived using Wilson's estimate:
where p5ðN SFAA þ 2Þ=ðN Total þ 4Þ; N SFAA number of animals expressing SFAA, N Total number of animals per strain (Samuels and Witmer 2003) . Number of phenotyped animals varied among strains from 9 to 136 (median 5 26, total number of screened mice was 2367).
Crosses
To explore genetic mechanisms of SFAA, we generated several crosses: an F 2 intercross between the B6 and D2 strains (B6D2F 2 , n 5 89), recombinant inbred intercross (RIX) (Zou et al. 2005 ) between BXD1 and BXD38 (2 high SFAA incidence BXD RI strains, n 5 40), and several crosses between the parental strains, B6 and D2, and the highincidence BXD1 strain: 1) F 1 between the BXD1 and B6 (BXD1 Â B6F 1 , n 5 20) and BXD1 and D2 (BXD1 Â D2F 1 , n 5 20), 2) backcrosses between BXD1 and BXD1 Â B6F 1 (BC (BXD1B6F1 Â BXD1) , n 5 40) and BXD1 and BXD1 Â D2F 1 (BC (BXD1D2F1 Â BXD1) , n 5 40), 3) F 2 intercross between BXD1 Â B6F 1 (F 2(BXD1B6F1 Â BXD1B6F1) , n 5 222).
Mapping
Incidence of SFAA in each phenotyped BXD RI strain was submitted to Genenetwork database (phenotype ID no. 11033). We used the web based mapping tool WebQTL (www.genenetwork.org) for genome-wide quantitative trait locus (QTL) screening of SFAA. Genome-wide empirical threshold was determined by 1000 permutations.
However, classical linkage analysis relies on mapping one locus at a time, which may be not productive in the circumstances when the phenotype is an outcome of aggregate influence of 2 or more loci, particularly if they interact in a nonadditive manner. Therefore, we also used a stratified analysis in the mapping effort, which assumed that a high incidence of SFAA in 7 BXD RIs is the aggregate effect of shared alleles at relevant loci of the genome in these strains, whereas genotypes of the low incidence strains at each of the loci should be evenly distributed between the B6 and D2 progenitors. The phenotyped BXD RIs were partitioned into high (7 BXD RI strains) and low (23, 0% SFAA, BXD RI strains) SFAA incidence strata. First, we selected regions of the genome where at least 6/7 high strata strains shared the same allele. Then, the allelic frequencies at these selected regions were tested for deviation from the expected 50%B6/ 50%D2 in the low strata strains by means of v 2 test. Regions that did not deviate from expected (P ! 0.05) or those biased (P , 0.05) toward the alternative allele than in the high strata were identified as potentially involved in expression of SFAA.
Results
The present set of experiments has been designed to determine if variation in anatomical origin of soleus muscle described in the B6/D2 lineage as the SFAA phenomenon (Lionikas, Glover, et al. 2006 ) is a hereditary phenomenon and to characterize its nature.
Parental and BXD RI Strains
In the parental strains, B6 exhibited a 4% and D2, a 2%, incidence of SFAA. Among the BXD RI strains SFAA incidence varied widely (Figure 2) . Seven of the strains (BXD1, 12, 38, 43, 48, 54 , and 56) exhibited 47-89% incidence of SFAA, 11 strains ranged between 8% and 39% (BXD11, 13, 16, 28, 29, 32, 34, 51, 61, 69, and 96) , 14 strains ranged between 1% and 6% (BXD2, 14, 18, 19, 22, 23, 27, 30, 31, 33, 40, 44, 60, and 84) , and the remaining 23 scored 0% SFAA (BXD6, 8, 9, 21, 24, 36, 39, 42, 45, 62, 63, 66, 70, 73, 75, 77, 85, 86, 87, 89, 90, 97, and 99) . Considering possible genetic mechanisms underlying this variation, that is, expression of SFAA versus typical origin of soleus, the fact that SFAA was rare in both parental strains but frequent in 7 derivative BXD RI strains and that the strain distribution pattern exhibited a range of SFAA incidence among the BXD RIs ( Figure 2 ) was not consistent with a single gene model but instead strongly favors a polygenic system.
A characteristic feature of SFAA is its unilateral expression. A bilateral analysis of 273 mice from the 7 highincidence strains (128 males and 145 females) revealed that 64% of animals expressed SFAA: the percentage was similar for males (68%) and females (61%). Left and right hindlimbs were equally affected, 114 and 113, respectively. Unilateral incidence of SFAA was more frequent, 0.46, than bilateral, 0.19. The fact that the bilateral incidence approximates the square of the unilateral, 0.21, is consistent with the idea that the mechanisms involved in the development of SFAA act independently in the left and right hindlimbs of the embryo. Thus, although the genetic factors seem to play an important role in the development of SFAA (cf. the wide variation across BXD RI strains), it is the interaction between those factors and the local environment that determines the anatomic site of origin of each soleus.
Crosses
RIX
We examined whether high-incidence SFAA strains had a common genetic etiology by intercrossing BXD1 (89% incidence) and BXD38 (60% incidence). We hypothesized that the allelic configuration of the genes underlying SFAA was shared between the 2 strains, and that therefore a similar incidence of SFAA would be observed in their offspring, RIX cross. However, SFAA was significantly lower in the RIX cross, (8%; v 2 vs. BXD1 and BXD38, both, P ,, 0.001; Table 1 ), indicating only a limited overlap of relevant alleles between the strains. Alternatively, the expression of SFAA could have been masked by the background heterozygosity of the RIX hybrids that would tend to promote developmental stability.
F 1
In the BXD1 Â B6F 1 , the B6 portions of the BXD1 genome remained homozygous, whereas the D2 became heterozygous. Significantly, (v 2 , P ,, 0.001) lower incidence of SFAA in the BXD1 Â B6F 1 (10%) than that in the BXD1 (89%) indicated an important role of gene(s) in the D2 portion of the BXD1 genome (Table 1) . This cross also revealed that one D2 allele at a relevant locus or loci is sufficient to develop SFAA in 10% of animals. Following the same logic, the relevance of the B6 portion of the genome in the BXD1 strain was explored in the BXD1 Â D2F 1 mice. None of 40 BXD1 Â D2F 1 animals expressed SFAA indicating that mechanisms underlying its development were disrupted in the B6 portion of the BXD1 genome and implying that B6 homozygosity at a relevant locus or loci is critical for this phenomenon. This part of the experiment provided results consistent with a polygenic nature for SFAA. As both B6 and D2 portions of the genome of BXD1 strain contribute to the incidence of SFAA, at least one gene from each portion is involved.
Backcross
Genomic regions of the BXD1, which are homozygous for the D2 allele will segregate in the BC (BXD1B6F1 Â BXD1) population and those homozygous for the B6 allele, in the BC (BXD1D2F1 Â BXD1) population. Comparison of the incidence of SFAA between the backcrosses (Table 1) indicated that it was significantly higher in the BC (BXD1B6F1 Â BXD1) than in the BC (BXD1D2F1 Â BXD1) population, 33% versus 8%, respectively (v 2 , P ,, 0.001). However, incidence in both backcross populations was markedly reduced compared with the 89% seen in the BXD1 strain, arguing for the importance of allelic differences in both D2 and B6 portions of the BXD1 genome and for the idea that SFAA may be promoted by an interaction between homozygous D2 and B6 alleles. Consistent with the F 1 findings, heterozygosity at the B6 regions reduced SFAA incidence to a greater degree.
Genotypes of the B6 portion of BXD1 genome are fixed in the F 2(BXD1B6F1 Â BXD1B6F1) population but those in the D2 portion are segregating. The D2 portion of the genome was chosen for probing because of the expected higher yield of D, homozygous for D2; H, heterozygous; B, homozygous for B6. a Deviation of the allelic frequency from 50/50 among the strains expressing no-SFAA was tested using the v 2 test. NS indicates no significant deviation, D2 . B6 indicates that overrepresentation of the D2 allele, whereas B6 . D2, overrepresentation of the B6 allele. b IDs and genotypes of 3 B6D2F 2 males from the aging study ) expressing SFAA. In instances where genotypes were not available at the same markers as used in BXD RI strains, allelic notation such as for example H-D indicates genotype change from H proximally to D distally between the proximal and distal markers flanking candidate region.
SFAA-positive animals (heterozygosity at all D2 loci resulted in 10% SFAA incidence in the BXD1 Â B6F 1 mice). We found that 10% of the 222 F 2(BXD1B6F1 Â BXD1B6F1) mice expressed SFAA (Table 1) further supporting the hereditary influence on the phenomenon.
B6D2F 2
This population exhibited a 2% incidence of SFAA, which is a significant (v 2 , P ,, 0.001) reduction compared with that of the F 2(BXD1B6F1 Â BXD1B6F1) animals where alleles segregated only in the D2 portion of the BXD1 genome. This incidence of SFAA compared well with that observed in another F 2 intercross of the B6 and D2 strains, which was phenotyped unilaterally for muscle weight, genotyped, and subjected to linkage analysis . Of 321 mice phenotyped in that study 3 males expressed SFAA. Because only the right hindlimb was examined, a correction for the unilateral phenotyping was made, and the results were a very close match with the incidence predicted by the B6D2F 2 intercross of the present study.
Mapping Using Stratified Groups and QTL Approach
In the stratified analysis, first we selected genomic loci where the same allele was found in at least 6 of 7 high strata strains. Allowance of one mismatch was based on the RIX findings that alleles are shared not at every relevant locus of the BXD1 and BXD38 strains. A total of 37 such regions was found on Chr 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 , and X, 18 of them carrying B6 and 17, D2 alleles (Figure 3) . Testing for the allelic frequency in low strata reduced the number of loci to 31 because of the bias toward the high strata allele in 6 regions ( Table 2) .
QTL analyses identified a suggestive QTL on Chr 11 and three linked QTL on Chr 14 (Figure 4) , one of which was statistically significant at the genome-wide P , 0.05 (Lander and Kruglyak 1995) . Position and the allelic effects of the QTL overlapped with the corresponding characteristics of the regions identified on Chr 11 and 14 via the stratified analysis (Table 2) . Overall, both stratified and QTL analysis resulted in a number of genomic regions plausibly involved in the expression of SFAA, which will be important targets in further explorations of the underlying mechanisms.
Estimating Number of Genes
Information from the BXD1 RI crosses was used to obtain an estimate of the number of genes involved in SFAA. In total, 16/18 BXD1 mice expressed SFAA, and we assumed that derivative BC or F 2 animals replicating genotype of BXD1 at the relevant loci would exhibit the same incidence of the phenomenon. In a single gene model, half of the backcross population is heterozygous and another half homozygous at the relevant locus. From the BXD1 Â D2F 1 , we know that heterozygosity in the B6 Figure 3 . Stratified analysis of the genomic loci associated with SFAA. Chromosome position and genotype of representative single nucleotide polymorphisms (B, C57BL/6; D, DBA/2; H, heterozygous) in high-incidence BXD RI strains (high) and BXD RI strains expressing no SFAA (low) at the regions presented in Table 2 . Underlined P values of v 2 test (Chi2) indicate a significant bias toward high strata allele. portion of the BXD1 genome precludes expression of SFAA, thus only homozygotes would be contributing to its incidence in the BC (BXD1D2F1 Â BXD1) and 18 SFAA-positive out of 40 tested animals would be expected (based on the 89% incidence in BXD1). Yet, the actual incidence of SFAA was substantially lower, 3% (v 2 , P ,, 0.001), rejecting a single gene model. Two and 3 gene models were tested in the same manner, and for the BC (BXD1B6F1 Â BXD1) , it was taken into account that heterozygous animals also contributed to the incidence. Results of this analysis are presented in Table 3 , indicating that a 2-gene and a 3-gene models did not deviate significantly from the observed incidence in the BC (BXD1B6F1 Â BXD1) and BC (BXD1D2F1 Â BXD1) populations, respectively. Consistently with the BC (BXD1B6F1 Â BXD1) findings, a 2-gene model was also the best fit of the F 2(BXD1B6F1 Â BXD1B6F1) SFAA incidence data. Overall, this analysis further supported a polygenic nature of the phenotype indicating that 2 genes in the B6 and 3 genes in the D2 portions of the BXD1 genome were involved in the expression of SFAA.
Discussion
Skeletal muscles, by virtue of their anatomic and functional properties, significantly contribute to a distinctive gait and posture. Variations in the musculoskeletal attachment in the hindlimbs are not uncommon in humans (Ekenman et al. 1995; Barberini et al. 2003 ) and might be exacerbating factors for conditions such as shin splint in response to physical activity (Ekenman et al. 1995) . The SFAA phenomenon in mice can be utilized to study the mechanisms underlying variation in musculoskeletal development.
It was important to understand whether SFAA is a hereditary condition and a characteristic trait of the B6/D2 lineage, which can be used as a model to elucidate the mechanisms underlying genetic variation of musculoskeletal phenotypes, or a congenital phenomenon that would be difficult to explore due to its low incidence. A high incidence of SFAA in several strains makes this phenomenon amenable for the exploration of its underlying mechanisms. Furthermore, it appeared to be a reproducible feature of the B6/D2 lineage (and not a result of chance mutations within specific RI strains) as high-incidence RI strains emerged among BXD strains independently developed from different B6 and D2 progenitors at substantial intervals over a period of approximately 30 years (Taylor 1978; Taylor et al. 1999; Peirce et al. 2004) .
A panel of BXD RI strains has been developed to study the genetic architecture of complex phenotypes (Taylor 1978; Taylor et al. 1999; Peirce et al. 2004) . Various crosses among strains differing in qualitative phenotypes have been a classical tool in early genetic research (Wright 1934) . By crossing the BXD1 strain (high SFAA incidence) to both parental strains and studying their F 1 offspring, we determined that the incidence of SFAA markedly decreased due to the genotypic differences in the portions of the BXD1 genome carrying alleles of the B6 or D2 progenitors. Furthermore, the gene(s) in the B6 portion act as recessive susceptibility genes in the expression of SFAA, incidence of which was abolished by their heterozygosity in the BXD1 Â D2F 1 s. Meanwhile, heterozygosity in the D2 portion of BXD1 genome of the BXD1 Â B6F 1 s resulted in SFAA incidence of 10%, albeit at a substantially reduced rate compared with the BXD1, 89%. Together these findings indicate that the genetic architecture of SFAA consists of susceptibility and modifier gene(s) located predominantly in the B6 and D2 portions of BXD1 genome, respectively.
Our findings of SFAA in the B6D2F 2 population (where alleles are segregating in both susceptibility and modifier regions of the genome), however, argue against the recessiveness of relevant genes. The genotypes of the 3 SFAA-expressing B6D2F 2 s at the loci identified in the stratified analysis are presented in Table 2 . Although genotyped markers do not permit us to determine the genotypes of the regions of interest unambiguously, it appears that these 3 males share no homozygous genotypes at any of the autosomal regions or actually any other marker across the genome (data not shown), however, the distal region on the X chromosome emerged as an interesting candidate for further exploration. It is not clear, however, if this discrepancy in recessiveness could be attributed to the limited sample size of the BXD1 Â D2F1 population or a difference in the genetic background (heterozygosity in the B6D2F 2 population was possible throughout the entire genome vs. only in the B6 portion of the BXD1 genome in the BXD Â D2F1 population).
It is important to understand if the same genetic architecture underlies SFAA in other high-incidence strains. There was a noticeable variability of SFAA rate among 7 strains, 47%-through-89%, therefore, it is possible that mechanisms underlying the phenomenon also varied. By crossing BXD1 and BXD38 strains, we found that the incidence was markedly reduced in their offspring. Only 2 alleles, B6 or D2, at any given locus exist in any of the derivative crosses. Therefore, it is only possible that B6B6, D2D2 and D2D2, B6B6 allelic configurations at 2 hypothetical loci result in high incidence of SFAA in the BXD1 and BXD38, respectively, whereas B6D2, B6D2 in the RIX does not. Such complexity hinders further characterization of the genetic architecture and calls for examination of various crosses between the high-incidence BXD RI strains in order to nominate reliably candidate regions underlying SFAA.
Considering the candidate gene approach, it is likely that variation in soleus origin appearing as SFAA results from the polymorphisms in genes involved in interaction between bone, tendon, and muscle precursors. Exploration of musculoskeletal development in the embryo identified several regulatory proteins important for the interaction of muscle, tendon, and bone tissues (reviewed by Tozer and Duprez 2005) . Genes coding for proteins MyoD (Chr7, 53.6 Mb), Erk1 (Chr7, 133.9 Mb), Fgf4 (Chr7, 152.2 Mb), Myf5 (Chr10, 107.0 Mb), and Pea3 (Chr11, 101.6 Mb) are within or in close proximity to the genomic regions identified by our analysis, indicating them as possible candidates. Furthermore, exploration of NCBI database (www.ncbi.nlm.nih.gov) revealed that genes critical for the development of skeletal muscle, Myf5 and MyoD, are polymorphic between the B6 and D2 strains. The role of a Prediction of the incidence in each cross (expected number of SFAA among tested mice) was based on the assumption that allelic configuration conferring 89% of SFAA in the BXD1 strain will also result in the same incidence in various crosses. Prediction for the BC (BXD1D2F1 Â BXD1) is higher than for the other backcross because the contribution of heterozygous animals to the incidence of SFAA (10%, based on BXD1D2F1 observation).
these candidates in development of SFAA remains to be tested. A recent study on the transcription factor and a marker of tendon development, scleraxis, showed the range of effects of the gene knockout on various tendons (Murchison et al. 2007 ). Specifically, force-transmitting and intermuscular tendons were disrupted (from complete absence to formation of poorly organized tendons), whereas anchoring tendons were less affected and remained functional. Such specificity indicates that different mechanisms might be involved depending on the anatomical location, which is in accord with the fact that SFAA is not accompanied by any other gross anatomical abnormality of hindlimb muscles.
An alternative explanation of SFAA incidence particularly in crosses involving high-incidence strains is that the low incidence reflects variations in developmental stability (Waddington 1942) as a result of the degree of background heterozygosity. To address this issue, we examined the genotypes of the BXD1 and BXD38 strains (Peirce et al. 2004 ) to obtain a heterozygosity index. Among the 13368 single nucleotide polymorphism markers genotyped in the parental and BXD1 and BXD38 strains (http: //www.well.ox.ac.uk/mouse/INBREDS/), 7516 were found to be polymorphic between B6 and D2 strains. Among those, 3637 were polymorphic between the BXD1 and BXD38 RI strains. There was a slight marker genotype bias (;60%/40%) toward the B6 alleles in the BXD1 strain and toward the D2 alleles in the BXD38 strain. If heterosis (rather than specific genomic regions) is considered as a major factor in SFAA incidence, then populations of individuals with a larger number of polymorphic markers would be predicted to be associated with a decrease in its incidence. However, the SFAA incidence in RIX, BXD1 Â B6F 1 , and BXD1D2F 1 crosses (8%, 10%, and 0%, respectively), where each mouse has a heterozygosity index of 3637, 1452, and 2185 markers, respectively, are not consistent with this scenario.
In summary, findings in the BXD RIs and various crosses provided evidence that the incidence in variation of anatomical origin of soleus muscle, fibular origin (normal) versus SFAA, is 1) an outcome of aggregate effect of more than one gene, 2) relevant genes are located in both B6 and D2 portions of the BXD1 genome, 3) one or more gene(s) in the B6 portion function as susceptibility genes, 4) not all relevant genes are in the same allelic configuration between 2 high-incidence strains, BXD1 and BXD38.
We conclude that SFAA is a polygenic trait, and we identified 31 loci on 16 different chromosomes that may harbor genes involved in the development of the phenotype. Further experiments are required to verify nominated candidate loci.
